Reports
Reports
Sale
The global smart diabetes management market attained a value of USD 6.04 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 14.75% to reach USD 21.00 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is the leading market in the industry. The smart diabetes management market in the region is being driven by the high presence of key players who have a diversified product portfolio and the early adoption of technologically advanced treatment techniques. With a growing towards among the patients for the self-management of the disease, the market in the region is being further propelled forward. The Asia Pacific and Europe are also significant markets in the industry due to the rising population of the patients afflicted with diabetes in the regions.
Smart diabetes management help to manage diabetes by increasing patient compliance and helping an individual maintain their blood glucose levels, which is an essential component for controlling diabetes. It contains devices that are integrated with mobile applications via Bluetooth or USB and includes devices like blood glucose monitoring and insulin delivery devices.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on products, the smart diabetes management market can be divided into:
The market can be broadly categorised based on its applications segments as:
Based on its end-use segments, the industry can be divided as:
The EMR report looks into the regional markets of smart diabetes management like the Asia Pacific, the Middle East and Africa, Europe, Latin America, and North America.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is being driven by the rising prevalence of diabetes and a growing demand for self-diabetes management. The rising innovation and product diversification in the industry is expected to drive the market in the coming years. The increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions, is expected to catalyse the industry growth the further. The growing trend of healthcare IT and connected healthcare is expected to propel the industry further forward.
The report presents a detailed analysis of the following key players in the global smart diabetes management market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Device Type |
|
Breakup by Applications |
|
Breakup by Diseases Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Smart Diabetes Management Market Overview
3.1 Global Smart Diabetes Management Market Historical Value (2017-2023)
3.2 Global Smart Diabetes Management Market Forecast Value (2024-2032)
4 Global Smart Diabetes Management Market Landscape
4.1 Global Smart Diabetes Management Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Smart Diabetes Management Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Device Type
4.2.3 Analysis by End User
5 Global Smart Diabetes Management Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Smart Diabetes Management Market Segmentation
6.1 Global Smart Diabetes Management Market by Product Type
6.1.1 Market Overview
6.1.2 Smart Glucose Meters
6.1.3 Continuous Glucose Monitoring Systems
6.1.4 Smart Insulin Pens
6.1.5 Smart Insulin Pumps
6.1.6 Closed Loop Systems
6.1.7 Other
6.2 Global Smart Diabetes Management Market by Device Type
6.2.1 Market Overview
6.2.2 Handheld Devices
6.2.3 Wearable Devices
6.3 Global Smart Diabetes Management Market by Applications
6.3.1 Market Overview
6.3.2 Diabetes
6.3.3 Blood Glucose Tracking
6.3.4 Obesity Management
6.3.5 Diet Management Apps
6.3.6 Others
6.4 Global Smart Diabetes Management Market by Diseases Type
6.4.2 Type 1 Diabetes
6.4.3 Type 2 Diabetes
6.5 Global Smart Diabetes Management Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Clinics
6.5.4 Home Healthcare
6.5.5 Others
6.6 Global Smart Diabetes Management Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Smart Diabetes Management Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Smart Diabetes Management Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Smart Diabetes Management Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Smart Diabetes Management Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Smart Diabetes Management Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 PHC Holdings Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 WellDoc, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sanofi SA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Dexcom, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 DarioHealth Corp.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medtronic pls
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 B. Braun SE
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Insulet Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Ascensia Diabetes Care Holdings AG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Tidepool
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Tandem Diabetes Care
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 LifeScan
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 AgaMatrix
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Glooko Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Smart Diabetes Management Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the global smart diabetes management market attained a value of nearly USD 6.04 billion.
The market is projected to grow at a CAGR of 14.75% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 21.00 billion by 2032.
The major drivers of the industry include rising prevalence of diabetes, growing demand for self-diabetes management, rising innovation, and product diversification in the industry, and increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions.
The growing trend of healthcare IT and connected healthcare is expected to be a key trend guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
The types of smart diabetes management available are smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, and closed loop systems.
Smart diabetes management finds applications as type 1 diabetes and type 2 diabetes.
Smart diabetes management can have different end-uses like home healthcare, hospitals, and specialty diabetes clinics.
The leading players in this market are F. Hoffmann-La Roche, Ltd., Medtronic, Inc., Dexcom, Inc., Insulet Corporation, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, and Glooko, among others.
The global smart diabetes management market attained a value of USD 6.04 billion in 2023, driven by the rising prevalence of diabetes, growing demand for self-diabetes management, rising innovation and product diversification in the industry and increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions. Aided by the growing trend of healthcare IT and connected healthcare, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 14.75%. The market is projected to reach USD 21.00 billion by 2032.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the products, the smart diabetes management market can be segmented into smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, and closed loop systems. By application, the industry can be divided into type 1 diabetes and type 2 diabetes. Smart diabetes management can have different end-uses like home healthcare, hospitals, and specialty diabetes clinics. The major regional markets for smart diabetes management are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include F. Hoffmann-La Roche, Ltd., Medtronic, Inc., Dexcom, Inc., Insulet Corporation, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, and Glooko, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.